CEL-SCI CorporationCVMNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank59
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P59
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
3 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-0.69%
Q3 2025-1.00%
Q2 2025-6.83%
Q1 2025-9.39%
Q4 2024-1.05%
Q3 2024-4.80%
Q2 20241.61%
Q1 20246.34%
Q4 2023-17.37%
Q3 2023-8.03%
Q2 2023-5.85%
Q1 202312.81%
Q4 2022-16.54%
Q3 20222.78%
Q2 2022-3.63%
Q1 20227.24%
Q4 202114.98%
Q3 2021-26.34%
Q2 202137.55%
Q1 2021-3.57%
Q4 20201.62%
Q3 202036.18%
Q2 2020-11.12%
Q1 20204.90%
Q4 2019-10.77%
Q3 2019104.61%
Q2 2019-8.98%
Q1 2019-19.37%
Q4 201885.73%
Q3 2018-30.47%
Q2 2018-18.12%
Q1 201827.36%
Q4 2017167.38%
Q3 2017-76.21%
Q2 2017-48.17%
Q1 201775.29%
Q4 2016-14.65%
Q3 2016-2.53%
Q2 20164.53%
Q1 2016-9.97%